Share Price and Basic Stock Data
Last Updated: October 22, 2025, 5:26 am
| PEG Ratio | -28.53 |
|---|
Analyst Insight & Comprehensive Analysis
Business Overview and Revenue Trends
Zodiac JRD MKJ Ltd operates within the gems, jewellery, and precious metals industry. The company recorded a market capitalization of ₹51.5 Cr and a share price of ₹46.9. Its revenue from operations for the year ending March 2025 stood at ₹22.99 Cr, reflecting a significant recovery from previous years, particularly the recorded ₹15.10 Cr in March 2023 and ₹10.89 Cr in March 2024. Quarterly sales have shown fluctuations, with a notable peak of ₹6.46 Cr in June 2024. However, the company has also experienced downturns, as seen with a decline to ₹1.09 Cr in March 2023. The operating profit margin (OPM) was reported at 4.29%, indicating a modest profitability level. The company’s cash conversion cycle was exceptionally long at 1,059.20 days, suggesting inefficiencies in inventory management and receivables collection, which could hinder operational cash flow. Overall, while Zodiac JRD MKJ Ltd shows potential for growth, the volatility in revenue and operational efficiency requires careful monitoring.
Profitability and Efficiency Metrics
The profitability metrics for Zodiac JRD MKJ Ltd present a mixed picture. The return on equity (ROE) stood at 0.64%, while the return on capital employed (ROCE) was notably low at 1.41%. These figures are below the typical benchmarks in the jewellery sector, which often aims for higher returns. The company showed a net profit of ₹0.43 Cr, with an earnings per share (EPS) of ₹0.83 for the fiscal year ending March 2025, recovering from a loss of ₹2.64 Cr in the previous year. Despite this improvement, the interest coverage ratio (ICR) was at 2.89x, reflecting a capability to cover interest expenses but still indicating a reliance on debt financing. The operating profit fluctuated significantly, with a decline to -₹4.03 Cr in March 2024, highlighting periods of operational distress. The OPM has also been inconsistent, with a recent recovery to 4.44% in March 2025 after periods of negative margins. This inconsistency in profitability metrics underlines the need for strategic operational improvements.
Balance Sheet Strength and Financial Ratios
Zodiac JRD MKJ Ltd’s balance sheet reflects a conservative financial structure, with total borrowings of ₹0.49 Cr, leading to a debt-to-equity ratio of 0.01, indicating minimal reliance on debt. The company reported reserves amounting to ₹62.75 Cr, which bolsters its equity base. The current ratio is exceptionally high at 33.36, suggesting strong short-term liquidity and the ability to meet current liabilities. However, the quick ratio of 11.94 indicates that while the company can cover its short-term obligations, it may face challenges in converting inventory into cash. The book value per share was ₹131.21, showcasing a solid equity position relative to its market price. The enterprise value (EV) was at ₹23.72 Cr, and the EV to EBITDA ratio stood at 23.23, suggesting the market may perceive the company as overvalued compared to its earnings. Overall, while the balance sheet appears robust, the high liquidity ratios coupled with low profitability metrics indicate an inefficiency that management must address.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Zodiac JRD MKJ Ltd has undergone notable changes, with promoters holding 39.25% as of June 2025, down from 45.80% in September 2022. The public shareholding increased from 54.19% in September 2022 to 60.75% in June 2025. This shift indicates a growing confidence among retail investors, possibly driven by the recent uptick in financial performance. The number of shareholders rose to 4,655, reflecting increased interest in the company’s stock. However, the fluctuation in promoter holdings could signal potential concerns about long-term commitment from the original owners. The decrease in promoter shareholding to as low as 10.67% in December 2023 raises questions about the company’s governance and strategic direction. Overall, while the increase in public participation may be a positive sign, the declining promoter stake may affect investor confidence moving forward.
Outlook, Risks, and Final Insight
If Zodiac JRD MKJ Ltd can sustain its recent revenue growth and improve operational efficiencies, it could enhance its profitability metrics, particularly in terms of OPM and ROCE. However, the company faces risks from its long cash conversion cycle, which may impede cash flow and operational agility. Additionally, the declining promoter shareholding could lead to governance issues, potentially affecting strategic decision-making. The company’s reliance on minimal debt provides a cushion against financial distress, but it also limits its ability to leverage growth opportunities. If management focuses on enhancing inventory management and receivables collection, it could significantly improve operational cash flow. Furthermore, maintaining investor confidence through transparent governance practices and strategic initiatives will be crucial for long-term sustainability and growth in the competitive gems and jewellery sector.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of Zodiac JRD MKJ LTD
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Mini Diamonds (India) Ltd | 343 Cr. | 145 | 233/97.5 | 100 | 26.6 | 0.00 % | 16.2 % | 12.6 % | 10.0 |
| Mishka Exim Ltd | 53.5 Cr. | 37.0 | 70.5/25.0 | 111 | 15.2 | 0.00 % | 2.29 % | 1.60 % | 10.0 |
| Motisons Jewellers Ltd | 1,664 Cr. | 16.9 | 33.8/15.4 | 37.1 | 4.20 | 0.00 % | 14.5 % | 11.6 % | 1.00 |
| Nanavati Ventures Ltd | 48.4 Cr. | 104 | 163/35.9 | 210 | 48.2 | 0.00 % | 1.39 % | 1.03 % | 10.0 |
| Gautam Gems Ltd | 16.5 Cr. | 4.04 | 7.79/3.41 | 45.8 | 12.6 | 0.00 % | 1.35 % | 0.55 % | 10.0 |
| Industry Average | 1,252.00 Cr | 100.33 | 60.51 | 86.03 | 0.07% | 6.93% | 5.13% | 6.53 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 12.96 | 0.13 | 1.03 | 1.09 | 5.93 | 1.91 | 3.04 | 0.00 | 6.46 | 6.23 | 5.54 | 4.75 | 4.20 |
| Expenses | 12.09 | 0.16 | 1.07 | 1.53 | 6.13 | 1.58 | 4.13 | 3.07 | 6.50 | 5.96 | 5.22 | 4.60 | 4.02 |
| Operating Profit | 0.87 | -0.03 | -0.04 | -0.44 | -0.20 | 0.33 | -1.09 | -3.07 | -0.04 | 0.27 | 0.32 | 0.15 | 0.18 |
| OPM % | 6.71% | -23.08% | -3.88% | -40.37% | -3.37% | 17.28% | -35.86% | -0.62% | 4.33% | 5.78% | 3.16% | 4.29% | |
| Other Income | 0.07 | 0.00 | 0.24 | 0.45 | 1.20 | 0.09 | 0.16 | 0.55 | 0.09 | 0.09 | 0.00 | 0.16 | 0.03 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.06 | 0.09 | 0.13 | 0.09 |
| Depreciation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
| Profit before tax | 0.94 | -0.03 | 0.20 | 0.01 | 1.00 | 0.42 | -0.93 | -2.52 | 0.04 | 0.29 | 0.22 | 0.17 | 0.11 |
| Tax % | 25.53% | 200.00% | -40.00% | -1,000.00% | 12.00% | -14.29% | 1.08% | -28.97% | 0.00% | 0.00% | 0.00% | 105.88% | 0.00% |
| Net Profit | 0.70 | -0.10 | 0.28 | 0.11 | 0.89 | 0.47 | -0.94 | -1.79 | 0.04 | 0.28 | 0.21 | -0.01 | 0.11 |
| EPS in Rs | 0.64 | -0.09 | 0.25 | 0.10 | 0.81 | 0.43 | -0.85 | -1.63 | 0.04 | 0.25 | 0.19 | -0.01 | 0.10 |
Last Updated: August 1, 2025, 9:00 am
Below is a detailed analysis of the quarterly data for Zodiac JRD MKJ LTD based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 4.20 Cr.. The value appears to be declining and may need further review. It has decreased from 4.75 Cr. (Mar 2025) to 4.20 Cr., marking a decrease of 0.55 Cr..
- For Expenses, as of Jun 2025, the value is 4.02 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 4.60 Cr. (Mar 2025) to 4.02 Cr., marking a decrease of 0.58 Cr..
- For Operating Profit, as of Jun 2025, the value is 0.18 Cr.. The value appears strong and on an upward trend. It has increased from 0.15 Cr. (Mar 2025) to 0.18 Cr., marking an increase of 0.03 Cr..
- For OPM %, as of Jun 2025, the value is 4.29%. The value appears strong and on an upward trend. It has increased from 3.16% (Mar 2025) to 4.29%, marking an increase of 1.13%.
- For Other Income, as of Jun 2025, the value is 0.03 Cr.. The value appears to be declining and may need further review. It has decreased from 0.16 Cr. (Mar 2025) to 0.03 Cr., marking a decrease of 0.13 Cr..
- For Interest, as of Jun 2025, the value is 0.09 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 0.13 Cr. (Mar 2025) to 0.09 Cr., marking a decrease of 0.04 Cr..
- For Depreciation, as of Jun 2025, the value is 0.01 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.01 Cr..
- For Profit before tax, as of Jun 2025, the value is 0.11 Cr.. The value appears to be declining and may need further review. It has decreased from 0.17 Cr. (Mar 2025) to 0.11 Cr., marking a decrease of 0.06 Cr..
- For Tax %, as of Jun 2025, the value is 0.00%. The value appears to be improving (decreasing) as expected. It has decreased from 105.88% (Mar 2025) to 0.00%, marking a decrease of 105.88%.
- For Net Profit, as of Jun 2025, the value is 0.11 Cr.. The value appears strong and on an upward trend. It has increased from -0.01 Cr. (Mar 2025) to 0.11 Cr., marking an increase of 0.12 Cr..
- For EPS in Rs, as of Jun 2025, the value is 0.10. The value appears strong and on an upward trend. It has increased from -0.01 (Mar 2025) to 0.10, marking an increase of 0.11.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: October 15, 2025, 4:06 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 21.07 | 20.23 | 16.09 | 18.06 | 20.00 | 14.85 | 12.54 | 8.67 | 19.02 | 15.10 | 10.89 | 22.99 | 20.72 |
| Expenses | 19.79 | 19.08 | 15.39 | 17.37 | 20.67 | 14.50 | 12.39 | 8.71 | 18.29 | 14.85 | 14.92 | 22.32 | 19.80 |
| Operating Profit | 1.28 | 1.15 | 0.70 | 0.69 | -0.67 | 0.35 | 0.15 | -0.04 | 0.73 | 0.25 | -4.03 | 0.67 | 0.92 |
| OPM % | 6.07% | 5.68% | 4.35% | 3.82% | -3.35% | 2.36% | 1.20% | -0.46% | 3.84% | 1.66% | -37.01% | 2.91% | 4.44% |
| Other Income | 8.94 | 0.37 | 0.27 | 1.04 | 1.44 | 1.66 | 0.59 | 0.31 | 0.32 | 0.87 | 2.01 | 0.35 | 0.28 |
| Interest | 0.00 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.35 | 0.37 |
| Depreciation | 0.12 | 0.24 | 0.06 | 0.06 | 0.07 | 0.05 | 0.03 | 0.02 | 0.02 | 0.01 | 0.00 | 0.06 | 0.04 |
| Profit before tax | 10.10 | 1.27 | 0.91 | 1.67 | 0.70 | 1.96 | 0.71 | 0.25 | 1.03 | 1.11 | -2.03 | 0.61 | 0.79 |
| Tax % | 28.12% | 40.16% | 30.77% | 23.35% | -2.86% | 23.47% | 29.58% | -40.00% | 33.98% | 10.81% | -32.51% | 29.51% | |
| Net Profit | 7.27 | 0.77 | 0.63 | 1.28 | 0.73 | 1.51 | 0.49 | 0.34 | 0.68 | 0.98 | -1.37 | 0.43 | 0.59 |
| EPS in Rs | 6.61 | 0.70 | 0.57 | 1.16 | 0.66 | 1.37 | 0.45 | 0.31 | 0.62 | 0.89 | -1.25 | 0.39 | 0.53 |
| Dividend Payout % | 3.56% | 33.64% | 41.11% | 20.23% | 35.48% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | -89.41% | -18.18% | 103.17% | -42.97% | 106.85% | -67.55% | -30.61% | 100.00% | 44.12% | -239.80% | 131.39% |
| Change in YoY Net Profit Growth (%) | 0.00% | 71.23% | 121.36% | -146.14% | 149.82% | -174.40% | 36.94% | 130.61% | -55.88% | -283.91% | 371.18% |
Zodiac JRD MKJ LTD has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 1% |
| 5 Years: | 13% |
| 3 Years: | 7% |
| TTM: | 82% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | -4% |
| 5 Years: | 0% |
| 3 Years: | -13% |
| TTM: | 127% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 3% |
| 5 Years: | 19% |
| 3 Years: | 14% |
| 1 Year: | -38% |
| Return on Equity | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | -1% |
| 3 Years: | -1% |
| Last Year: | 1% |
Last Updated: September 5, 2025, 1:56 pm
Balance Sheet
Last Updated: September 10, 2025, 2:51 pm
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 5.18 | 5.18 | 5.18 | 5.18 | 5.18 | 5.18 | 5.18 | 5.18 | 5.18 | 5.18 | 5.18 | 5.18 |
| Reserves | 58.21 | 58.67 | 58.98 | 59.54 | 59.97 | 61.17 | 61.66 | 62.02 | 62.71 | 63.69 | 62.32 | 62.75 |
| Borrowings | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.31 | 0.49 |
| Other Liabilities | 9.58 | 4.91 | 6.16 | 2.03 | 1.49 | 1.29 | 1.35 | 0.72 | 1.04 | 0.81 | 0.11 | 1.97 |
| Total Liabilities | 72.97 | 68.76 | 70.32 | 66.75 | 66.64 | 67.64 | 68.19 | 67.92 | 68.93 | 69.68 | 67.92 | 70.39 |
| Fixed Assets | 0.74 | 0.52 | 0.47 | 0.44 | 0.37 | 0.32 | 0.29 | 0.26 | 0.24 | 0.04 | 0.52 | 0.44 |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.06 | 0.06 |
| Investments | 15.11 | 12.54 | 10.74 | 9.85 | 8.54 | 5.21 | 5.59 | 2.94 | 1.74 | 1.70 | 0.00 | 0.00 |
| Other Assets | 57.12 | 55.70 | 59.11 | 56.46 | 57.73 | 62.11 | 62.31 | 64.72 | 66.95 | 67.94 | 67.34 | 69.89 |
| Total Assets | 72.97 | 68.76 | 70.32 | 66.75 | 66.64 | 67.64 | 68.19 | 67.92 | 68.93 | 69.68 | 67.92 | 70.39 |
Below is a detailed analysis of the balance sheet data for Zodiac JRD MKJ LTD based on the most recent figures (Mar 2025) and their trends compared to the previous period:
- For Equity Capital, as of Mar 2025, the value is 5.18 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 5.18 Cr..
- For Reserves, as of Mar 2025, the value is 62.75 Cr.. The value appears strong and on an upward trend. It has increased from 62.32 Cr. (Mar 2024) to 62.75 Cr., marking an increase of 0.43 Cr..
- For Borrowings, as of Mar 2025, the value is 0.49 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 0.31 Cr. (Mar 2024) to 0.49 Cr., marking an increase of 0.18 Cr..
- For Other Liabilities, as of Mar 2025, the value is 1.97 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.11 Cr. (Mar 2024) to 1.97 Cr., marking an increase of 1.86 Cr..
- For Total Liabilities, as of Mar 2025, the value is 70.39 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 67.92 Cr. (Mar 2024) to 70.39 Cr., marking an increase of 2.47 Cr..
- For Fixed Assets, as of Mar 2025, the value is 0.44 Cr.. The value appears to be declining and may need further review. It has decreased from 0.52 Cr. (Mar 2024) to 0.44 Cr., marking a decrease of 0.08 Cr..
- For CWIP, as of Mar 2025, the value is 0.06 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.06 Cr..
- For Investments, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
- For Other Assets, as of Mar 2025, the value is 69.89 Cr.. The value appears strong and on an upward trend. It has increased from 67.34 Cr. (Mar 2024) to 69.89 Cr., marking an increase of 2.55 Cr..
- For Total Assets, as of Mar 2025, the value is 70.39 Cr.. The value appears strong and on an upward trend. It has increased from 67.92 Cr. (Mar 2024) to 70.39 Cr., marking an increase of 2.47 Cr..
Notably, the Reserves (62.75 Cr.) exceed the Borrowings (0.49 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 1.28 | 1.15 | 0.70 | 0.69 | -0.67 | 0.35 | 0.15 | -0.04 | 0.73 | 0.25 | -4.34 | 0.18 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 240.97 | 197.75 | 240.69 | 339.94 | 261.89 | 290.28 | 289.90 | 455.93 | 369.41 | 413.10 | 405.89 | 296.89 |
| Inventory Days | 826.97 | 911.70 | 1,320.57 | 950.27 | 815.81 | 1,235.08 | 1,568.56 | 2,237.20 | 877.37 | 1,160.59 | 1,544.13 | 762.31 |
| Days Payable | 117.50 | 9.59 | 68.38 | 44.25 | 24.82 | 21.08 | 29.89 | 22.92 | 10.81 | 13.86 | 1.31 | 0.00 |
| Cash Conversion Cycle | 950.43 | 1,099.86 | 1,492.88 | 1,245.96 | 1,052.88 | 1,504.28 | 1,828.57 | 2,670.21 | 1,235.98 | 1,559.83 | 1,948.71 | 1,059.20 |
| Working Capital Days | 815.23 | 904.47 | 1,195.72 | 1,089.14 | 1,013.79 | 1,409.37 | 1,710.32 | 2,531.42 | 1,164.47 | 1,454.44 | 2,011.35 | 981.01 |
| ROCE % | 2.59% | 1.74% | 1.31% | 1.38% | 1.08% | 0.20% | 0.93% | -1.72% | 1.48% | 1.13% | -4.62% | 1.41% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 0.83 | -2.64 | 1.90 | 1.32 | 0.67 |
| Diluted EPS (Rs.) | 0.83 | -2.64 | 1.90 | 1.32 | 0.67 |
| Cash EPS (Rs.) | 0.94 | -2.63 | 1.93 | 1.36 | 0.71 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 131.21 | 130.38 | 133.02 | 131.12 | 129.79 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 131.21 | 130.38 | 133.02 | 131.12 | 129.79 |
| Revenue From Operations / Share (Rs.) | 44.40 | 21.02 | 29.17 | 36.73 | 16.75 |
| PBDIT / Share (Rs.) | 1.97 | -3.92 | 2.16 | 2.03 | 0.51 |
| PBIT / Share (Rs.) | 1.86 | -3.93 | 2.13 | 1.99 | 0.47 |
| PBT / Share (Rs.) | 1.18 | -3.94 | 2.13 | 1.99 | 0.47 |
| Net Profit / Share (Rs.) | 0.82 | -2.64 | 1.90 | 1.32 | 0.66 |
| PBDIT Margin (%) | 4.44 | -18.65 | 7.41 | 5.52 | 3.10 |
| PBIT Margin (%) | 4.18 | -18.69 | 7.31 | 5.41 | 2.83 |
| PBT Margin (%) | 2.64 | -18.72 | 7.31 | 5.41 | 2.83 |
| Net Profit Margin (%) | 1.86 | -12.57 | 6.51 | 3.59 | 3.97 |
| Return on Networth / Equity (%) | 0.63 | -2.02 | 1.42 | 1.00 | 0.51 |
| Return on Capital Employeed (%) | 1.41 | -3.00 | 1.60 | 1.51 | 0.36 |
| Return On Assets (%) | 0.60 | -2.01 | 1.41 | 0.99 | 0.50 |
| Total Debt / Equity (X) | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 |
| Asset Turnover Ratio (%) | 0.33 | 0.15 | 0.21 | 0.27 | 0.12 |
| Current Ratio (X) | 30.69 | 420.74 | 100.40 | 72.76 | 111.05 |
| Quick Ratio (X) | 10.99 | 120.86 | 37.49 | 28.02 | 28.88 |
| Inventory Turnover Ratio (X) | 0.50 | 0.00 | 0.01 | 0.00 | 0.01 |
| Interest Coverage Ratio (X) | 2.89 | -580.06 | 0.00 | 0.00 | 0.00 |
| Interest Coverage Ratio (Post Tax) (X) | 2.21 | -390.23 | 0.00 | 0.00 | 0.00 |
| Enterprise Value (Cr.) | 23.72 | 28.28 | 7.84 | 11.09 | 9.36 |
| EV / Net Operating Revenue (X) | 1.03 | 2.60 | 0.51 | 0.58 | 1.08 |
| EV / EBITDA (X) | 23.23 | -13.93 | 7.00 | 10.55 | 34.81 |
| MarketCap / Net Operating Revenue (X) | 1.23 | 3.10 | 0.97 | 0.86 | 1.49 |
| Price / BV (X) | 0.41 | 0.49 | 0.21 | 0.24 | 0.19 |
| Price / Net Operating Revenue (X) | 1.23 | 3.10 | 0.97 | 0.86 | 1.49 |
| EarningsYield | 0.01 | -0.04 | 0.06 | 0.04 | 0.02 |
After reviewing the key financial ratios for Zodiac JRD MKJ LTD, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 0.83. This value is below the healthy minimum of 5. It has increased from -2.64 (Mar 24) to 0.83, marking an increase of 3.47.
- For Diluted EPS (Rs.), as of Mar 25, the value is 0.83. This value is below the healthy minimum of 5. It has increased from -2.64 (Mar 24) to 0.83, marking an increase of 3.47.
- For Cash EPS (Rs.), as of Mar 25, the value is 0.94. This value is below the healthy minimum of 3. It has increased from -2.63 (Mar 24) to 0.94, marking an increase of 3.57.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 131.21. It has increased from 130.38 (Mar 24) to 131.21, marking an increase of 0.83.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 131.21. It has increased from 130.38 (Mar 24) to 131.21, marking an increase of 0.83.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 44.40. It has increased from 21.02 (Mar 24) to 44.40, marking an increase of 23.38.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 1.97. This value is below the healthy minimum of 2. It has increased from -3.92 (Mar 24) to 1.97, marking an increase of 5.89.
- For PBIT / Share (Rs.), as of Mar 25, the value is 1.86. This value is within the healthy range. It has increased from -3.93 (Mar 24) to 1.86, marking an increase of 5.79.
- For PBT / Share (Rs.), as of Mar 25, the value is 1.18. This value is within the healthy range. It has increased from -3.94 (Mar 24) to 1.18, marking an increase of 5.12.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 0.82. This value is below the healthy minimum of 2. It has increased from -2.64 (Mar 24) to 0.82, marking an increase of 3.46.
- For PBDIT Margin (%), as of Mar 25, the value is 4.44. This value is below the healthy minimum of 10. It has increased from -18.65 (Mar 24) to 4.44, marking an increase of 23.09.
- For PBIT Margin (%), as of Mar 25, the value is 4.18. This value is below the healthy minimum of 10. It has increased from -18.69 (Mar 24) to 4.18, marking an increase of 22.87.
- For PBT Margin (%), as of Mar 25, the value is 2.64. This value is below the healthy minimum of 10. It has increased from -18.72 (Mar 24) to 2.64, marking an increase of 21.36.
- For Net Profit Margin (%), as of Mar 25, the value is 1.86. This value is below the healthy minimum of 5. It has increased from -12.57 (Mar 24) to 1.86, marking an increase of 14.43.
- For Return on Networth / Equity (%), as of Mar 25, the value is 0.63. This value is below the healthy minimum of 15. It has increased from -2.02 (Mar 24) to 0.63, marking an increase of 2.65.
- For Return on Capital Employeed (%), as of Mar 25, the value is 1.41. This value is below the healthy minimum of 10. It has increased from -3.00 (Mar 24) to 1.41, marking an increase of 4.41.
- For Return On Assets (%), as of Mar 25, the value is 0.60. This value is below the healthy minimum of 5. It has increased from -2.01 (Mar 24) to 0.60, marking an increase of 2.61.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.01. This value is within the healthy range. It has increased from 0.00 (Mar 24) to 0.01, marking an increase of 0.01.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.33. It has increased from 0.15 (Mar 24) to 0.33, marking an increase of 0.18.
- For Current Ratio (X), as of Mar 25, the value is 30.69. This value exceeds the healthy maximum of 3. It has decreased from 420.74 (Mar 24) to 30.69, marking a decrease of 390.05.
- For Quick Ratio (X), as of Mar 25, the value is 10.99. This value exceeds the healthy maximum of 2. It has decreased from 120.86 (Mar 24) to 10.99, marking a decrease of 109.87.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 0.50. This value is below the healthy minimum of 4. It has increased from 0.00 (Mar 24) to 0.50, marking an increase of 0.50.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 2.89. This value is below the healthy minimum of 3. It has increased from -580.06 (Mar 24) to 2.89, marking an increase of 582.95.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 2.21. This value is below the healthy minimum of 3. It has increased from -390.23 (Mar 24) to 2.21, marking an increase of 392.44.
- For Enterprise Value (Cr.), as of Mar 25, the value is 23.72. It has decreased from 28.28 (Mar 24) to 23.72, marking a decrease of 4.56.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 1.03. This value is within the healthy range. It has decreased from 2.60 (Mar 24) to 1.03, marking a decrease of 1.57.
- For EV / EBITDA (X), as of Mar 25, the value is 23.23. This value exceeds the healthy maximum of 15. It has increased from -13.93 (Mar 24) to 23.23, marking an increase of 37.16.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 1.23. This value is within the healthy range. It has decreased from 3.10 (Mar 24) to 1.23, marking a decrease of 1.87.
- For Price / BV (X), as of Mar 25, the value is 0.41. This value is below the healthy minimum of 1. It has decreased from 0.49 (Mar 24) to 0.41, marking a decrease of 0.08.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 1.23. This value is within the healthy range. It has decreased from 3.10 (Mar 24) to 1.23, marking a decrease of 1.87.
- For EarningsYield, as of Mar 25, the value is 0.01. This value is below the healthy minimum of 5. It has increased from -0.04 (Mar 24) to 0.01, marking an increase of 0.05.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Zodiac JRD MKJ LTD:
- Net Profit Margin: 1.86%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 1.41% (Industry Average ROCE: 6.93%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 0.63% (Industry Average ROE: 5.13%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 2.21
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 10.99
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 88.1 (Industry average Stock P/E: 60.51)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.01
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 1.86%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Gems, Jewellery & Precious Metals | 506, 513, 5th Floor, 17G, Vardhaman Chamber, Mumbai Maharashtra 400001 | secretarial@zodiacjrdmkjltd.co.in http://www.zodiacjrdmkjltd.co.in |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Mahesh Ratilal Shah | Managing Director |
| Mr. Mudit Sharadkumar Jain | Non Exe.Non Ind.Director |
| Mr. Dharmesh Pravin Kharwar | Non Exe. & Ind. Director |
| Mrs. Rupal Patel | Non Exe. & Ind. Director |
| Mr. Jitendra Kanhaiyalal Purohit | Non Exe. & Ind. Director |
| Mr. Marc Christopher Weinmann | Non Exe.Non Ind.Director |
FAQ
What is the intrinsic value of Zodiac JRD MKJ LTD?
Zodiac JRD MKJ LTD's intrinsic value (as of 23 October 2025) is 28.43 which is 40.02% lower the current market price of 47.40, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 52.0 Cr. market cap, FY2025-2026 high/low of 75.1/36.2, reserves of ₹62.75 Cr, and liabilities of 70.39 Cr.
What is the Market Cap of Zodiac JRD MKJ LTD?
The Market Cap of Zodiac JRD MKJ LTD is 52.0 Cr..
What is the current Stock Price of Zodiac JRD MKJ LTD as on 23 October 2025?
The current stock price of Zodiac JRD MKJ LTD as on 23 October 2025 is 47.4.
What is the High / Low of Zodiac JRD MKJ LTD stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Zodiac JRD MKJ LTD stocks is 75.1/36.2.
What is the Stock P/E of Zodiac JRD MKJ LTD?
The Stock P/E of Zodiac JRD MKJ LTD is 88.1.
What is the Book Value of Zodiac JRD MKJ LTD?
The Book Value of Zodiac JRD MKJ LTD is 61.8.
What is the Dividend Yield of Zodiac JRD MKJ LTD?
The Dividend Yield of Zodiac JRD MKJ LTD is 0.00 %.
What is the ROCE of Zodiac JRD MKJ LTD?
The ROCE of Zodiac JRD MKJ LTD is 1.41 %.
What is the ROE of Zodiac JRD MKJ LTD?
The ROE of Zodiac JRD MKJ LTD is 0.64 %.
What is the Face Value of Zodiac JRD MKJ LTD?
The Face Value of Zodiac JRD MKJ LTD is 10.0.